LISA PEOPLES: Open Payments
NPI 1912180761 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,682 in 83 payments from 15 companies in 2025. Trend: 2023 $5,932 · 2024 $5,828 · 2025 $1,682
Food & beverage: $1,682
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $329 |
| ABBVIE INC. | 16 | $234 |
| GENZYME CORPORATION | 8 | $181 |
| Lilly USA, LLC | 3 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $137 |
| Madrigal Pharmaceuticals | 4 | $106 |
| Gilead Sciences, Inc. | 4 | $95 |
| Regeneron Healthcare Solutions, Inc. | 4 | $91 |
| Janssen Biotech, Inc. | 4 | $76 |
| Ardelyx, Inc. | 4 | $72 |
Products named: XIFAXAN, DUPIXENT, ENTYVIO, REZDIFFRA, TREMFYA, CREON, IBSRELA, Sucraid.
Industry payments across AL — which companies pay providers there.
